<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">Venous blood samples were taken on Days 4 and 5 immediately prior to G-CSF administration and then on each subsequent day of apheresis (~9–10 h post-plerixafor dosing) to evaluate the yield of peripheral blood CD34
 <sup>+</sup> cells using fluorescence-activated cell-sorting analysis. Yields evaluated by local laboratories were used for the primary analysis reported here.
</p>
